Bhagiradha Chemicals & Industries Limited Earnings Summary — Q1 FY2027
Bhagiradha Chemicals Reports Robust Q1 FY2027 Performance with 57.5% Revenue Growth and Net Profit Surge
Quarterly Business Intelligence
AI Quarterly Scorecard™
Computed deterministically from the last 10 reported quarters.
Quarterly Business Momentum
- Revenue has increased for 3 consecutive quarters.
- Revenue of ₹195 Cr is 57.6% higher year-on-year.
- Revenue has compounded at 28.3% annualised over the last 10 quarters.
- Revenue is at its highest level in 10 quarters.
- Net profit has reached its highest level in 10 quarters.
- Net profit of ₹13 Cr is 234.9% above the same quarter last year.
- Profit growth is outpacing revenue growth, pointing to positive operating leverage.
- Net profit has compounded at 35.9% annualised across the period.
- Operating margin stands at 15.7% in Q1 FY2027.
- Operating margin expanded by 839 bps year-on-year.
- Over the last two years operating margin has expanded by 489 bps.
- PBT margin is 9.0%.
- Expense growth of 43.3% remained below revenue growth of 57.6%.
- Operating profit of ₹31 Cr is 239.6% higher year-on-year.
- Operating leverage continues to improve.
- 6 of the last 6 measured quarters delivered year-on-year revenue growth.
- Overall quarterly business momentum scores 80/100 (Strong) on the latest 10 quarters.
- Business momentum remains positive heading into the next quarter.
Quarterly Financials
Last 10 Reported Quarters • All figures in ₹ Crore • Margins in %
| Metric | Trend | Latest Q1 FY2027 | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Improving | 195 | 158 | 114 | 140 | 124 | 123 | 103 | 104 | 111 | 111 |
| Expenses | Improving | 164 | 139 | 100 | 125 | 115 | 117 | 94 | 94 | 99 | 97 |
| Operating Profit | Accelerating | 31 | 19 | 14 | 15 | 9 | 6 | 9 | 10 | 12 | 14 |
| Operating Margin | Improving | 15.7% | 12.3% | 12.0% | 10.8% | 7.3% | 5.0% | 8.9% | 9.4% | 10.8% | 12.7% |
| Other Income | Volatile | 2 | 1 | 1 | 0 | 1 | 1 | 2 | 3 | 2 | 1 |
| Interest | Volatile | 6 | 7 | 3 | 4 | 3 | 2 | 2 | 2 | 1 | 2 |
| Depreciation | Strong Uptrend | 8 | 8 | 5 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
| Profit Before Tax | Volatile | 18 | 5 | 6 | 8 | 3 | 2 | 6 | 8 | 10 | 11 |
| Tax | Volatile | 4 | 1 | 2 | 2 | -1 | 3 | 2 | 2 | 4 | 3 |
| Net Profit | Volatile | 13 | 4 | 5 | 6 | 4 | -1 | 4 | 5 | 6 | 7 |
| Net Margin | Volatile | 6.8% | 2.6% | 4.0% | 3.9% | 3.2% | -0.7% | 3.5% | 5.2% | 5.1% | 6.5% |
Key Takeaways
- Revenue from operations surged 57.5% YoY to ₹19,501.89 lakhs, reflecting strong demand in the crop protection segment.
- Consolidated Net Profit witnessed a massive turnaround, growing 235% YoY to ₹1,332.92 lakhs.
- Bheema Fine Chemicals, the wholly-owned subsidiary, contributed significantly to the consolidated topline and margin expansion.
- Operating performance improved drastically despite a substantial increase in raw material consumption, aided by a large inventory build-up of ₹5,032 lakhs.
- Finance costs nearly doubled YoY to ₹642.95 lakhs, highlighting the impact of increased debt for recent CAPEX projects.
- Profitability was supported by a more favorable tax expense ratio compared to the prior year's same quarter.
- The company continues to operate as a single-segment entity focused exclusively on Crop Protection Chemicals.
Management Guidance
The company remains focused on ramping up its new manufacturing capacities and leveraging its specialized portfolio of 32 active ingredients to navigate the global agrochemical cycle.
Sentiment Shift
Improving
A sharp recovery in both topline and bottom-line margins suggests the company is beginning to benefit from its heavy CAPEX phase and capacity expansion.
Outlook
The successful integration and contribution from the subsidiary, coupled with a recovery in operating margins, position the company for a stronger fiscal year, provided global demand remains stable and inventory cycles normalize.
From the Annual Report (Key Quotes)
“The Board of Directors... approved the Un-Audited Financial Results (Standalone & Consolidated) for the Quarter ended June 30, 2026.”
“The Consolidated financials include the results of the Parent Company and Wholly owned Subsidiary - Bheema Fine Chemicals Private Limited.”
“The Group has only one reportable segment i.e Crop Protection Chemicals.”
Official Quarterly Documents
Ask AI about this quarter
This summary is AI-generated from Bhagiradha Chemicals & Industries Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.
← Back to Bhagiradha Chemicals & Industries Limited AI analysis